AtriCure (ATRC) Stock: Buy, Sell, or Hold?
ATRC - AtriCure, Inc.
$58.98
1.30 (2.26%)
▲
5d:
+2.07%
30d:
-1.63%
90d:
+68.31%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 03, 2026
11d
Get Alerted When ATRC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ATRC shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ATRC shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$21.13
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$13.12
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ATRC is currently trading at $58.98, which is considered extended relative to its 30-day fair value range of $55.00 to $58.87. From a valuation perspective, the stock is trading at a premium (Forward PE: 132.9) compared to its historical average (96.4). At these levels, the market is pricing in 11.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ATRC is in a strong uptrend. The price is approaching resistance at $59.29. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ATRC scores 27/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ATRC is in a strong uptrend. The price is approaching resistance at $59.29. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ATRC scores 27/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$55.00 -
$58.87
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
22.9%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (27/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($55.78)
- NEUTRAL: Trading at premium valuation - market expects 11.3% growth which is achievable
- WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$55.00 -
$58.87
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$51.63
Resistance Level
$59.29
Current Trend
Strong Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
132.88
Wall Street Target
$55.78
(-3.3%)
Revenue Growth (YoY)
12.8%
Profit Margin
1.8%
Valuation Premium vs History
+11.3% premium
PE vs Historical
132.9 vs 96.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+11.3%
(market-implied from PE analysis)
1-Year Target
$64.19
(+11%)
2-Year Target
$71.44
(+24%)
3-Year Target
$79.51
(+38%)
3-Yr Target (if PE normalizes)
(PE: 133→96)
PE COMPRESSION
$57.68
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 132.9, Growth: 52.7%)
$194.64
(+238%)
Base:
(SPY PE: 19.9, Growth: 52.7%)
$29.09
(-50%)
Bear:
(PE: 16.9, Growth: 52.7%)
$24.73
(-57%)
Share & Embed Analysis
Last updated: October 22, 2026 12:52 PM ET
Data refreshes hourly during market hours. Next update: 1:52 PM
Data refreshes hourly during market hours. Next update: 1:52 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ATRC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
STRONG BUY
34 analysts |
$479 | 32 SELL |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$83 | 37 SELL |
|
RGEN
Repligen Corporation |
STRONG BUY
22 analysts |
$198 | 49 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
17 analysts |
$413 | 41 HOLD |
|
STVN
Stevanato Group SpA |
BUY
14 analysts |
$24 | 63 BUY |
